Blue vitiligo.

The progression of vitiligo and postinflammatory hyperpigmentation simultaneously in a patient with AIDS led to the appearance of a blue color on much of the patient's skin. The blue coloration subsequently resolved with follicular repigmentation typical of resolving vitiligo. We believe this is the first reported case of "blue vitiligo."

• Publication year

  1994

• Venue

  Journal of American Academy of Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/s0190-9622(94)70089-3PMID 8169254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitiligo and chronic photosensitivity in human immunodeficiency virus infection.

  1991cited by this paper
• Nail and mucocutaneous hyperpigmentation with azidothymidine therapy.

  1990cited by this paper
• Pigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with zidovudine.

  1990cited by this paper
• Longitudinal melanonychia induced by 3'-azidodeoxythymidine. Report of 9 cases.

  1990cited by this paper
• Reticulate pigmentation due to bleomycin: light- and electron-microscopic studies.

  1990cited by this paper
• Nail dyschromia associated with zidovudine.

  1990cited by this paper
• Azidothymidine-induced nail pigmentation.

  1989cited by this paper
• Development of nail pigmentation during zidovudine therapy.

  1989cited by this paper
• Nail pigmentation associated with zidovudine.

  1989cited by this paper
• Azidothymidine-induced hyperpigmentation of skin and nails.

  1989cited by this paper
• Nail pigmentation associated with zidovudine.

  1989cited by this paper
• Azidothymidine-induced hyperpigmentation mimicking primary adrenal insufficiency.

  1989cited by this paper
• Nail pigmentation changes associated with azidothymidine (zidovudine).

  1987cited by this paper
• Human immunodeficiency virus—associated vitiligo: Expression of autoimmunity with immunodeficiency?

  1987cited by this paper
• Clinical toxicity of chemotherapeutic agents: dermatologic toxicity.

  1982cited by this paper
• Hyperpigmentation after bleomycin therapy

  1978cited by this paper

• A CollaboraTive Initiative of worldwide Vitiligo Experts and patients to define vitiligo activity (ACTIVE): study protocol

  2025cites this paper
• Clinical visible signs of disease activity in vitiligo: a systematic review and meta‐analysis

  2019cites this paper
• Vitiligo/nonsegmental Vitiligo Including Acrofacial and Universalis

  2019cites this paper
• Blaschkoid blue vitiligo

  2018cites this paper
• Blue vitiligo following intralesional injection of psoralen combined with ultraviolet B radiation therapy

  2015cites this paper
• Vitiligo: clinical aspects, quality of life and the role of melanocortin system in pathogenesis

  2013cites this paper
• Dermatoscopy of blue vitiligo

  2009cites this paper
• Vitiligo: compendium of clinico-epidemiological features.

  2007cites this paper
• Monte Carlo simulation of cutaneous reflectance and fluorescence measurements--the effect of melanin contents and localization.

  2007cites this paper
• Spectroscopic assessment of dermal melanin using blue vitiligo as an in vivo model

  2006influential citation
• An investigation into the role of autoimmunity in vitiligo.

  2002cites this paper
• Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo.

  1996cites this paper
• Blue vitiligo.

  1995cites this paper